Status:
UNKNOWN
Propofol Versus the Use of Dexmedetomidine as a Sedative Agent for Colonosopy
Lead Sponsor:
Tanta University
Conditions:
Colonic Diseases
Eligibility:
All Genders
25-45 years
Phase:
PHASE3
Brief Summary
Dexmedetomidine as a Sedative Agent for Patients Presented for Lower Gastrointestinal Endoscopy
Detailed Description
Propofol Versus the Use of Dexmedetomidine as a Sedative Agent for Patients Presented for Lower Gastrointestinal Endoscopy
Eligibility Criteria
Inclusion
- aged 25-45 years,
- ASA class I or II,
- who are scheduled for elective outpatient colonoscopy
Exclusion
- refused to give informed consent
- if they had known hypersensitivity to the used drugs
- patients with morbidly obese patients
- patients with increased risk for airway obstruction as obstructive sleep apnea,
- Liver diseases
Key Trial Info
Start Date :
April 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03466632
Start Date
April 1 2016
End Date
April 1 2020
Last Update
March 15 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sameh Abdelkhalek Ahmed
Zagazig, Egypt, 35455